Amneal Pharmaceuticals, Inc. Class A Common Stock Cash Flow Reinvestment Rate
Amneal Pharmaceuticals, Inc. Class A Common Stock cash flow reinvestment rate. Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) has a Cash Flow Reinvestment Rate of 0.39x as of September 2026, reinvesting $39.58 Million (capex $39.58 Million ) from operating cash flow of $100.28 Million. Explore how well can Amneal Pharmaceuticals, Inc. Class A Com service its debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Amneal Pharmaceuticals, Inc. Class A Common Stock (2014–2025)
Cash flow reinvestment rate of Amneal Pharmaceuticals, Inc. Class A Common Stock from 2014 to 2025. Historical reinvestment intensity for Amneal Pharmaceuticals, Inc. Class A Common Stock across 12 annual periods. Explore Amneal Pharmaceuticals, Inc. Class A Com (AMRX) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Amneal Pharmaceuticals, Inc. Class A Common Stock Cash Flow Reinvestment Rate by Year (2014–2025)
Amneal Pharmaceuticals, Inc. Class A Common Stock cash flow reinvestment rate by year from 2014 to 2025. Year-by-year capital reinvestment analysis for Amneal Pharmaceuticals, Inc. Class A Common Stock. For the full cash flow conversion analysis, see Amneal Pharmaceuticals, Inc. Class A Com operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.21x | $70.06 Million | $339.99 Million | $70.06 Million | ▼ -55.9% |
| 2024 | 0.47x | $137.99 Million | $295.10 Million | $74.99 Million | ▲ +16.8% |
| 2023 | 0.40x | $138.38 Million | $345.58 Million | $69.19 Million | ▼ -90.2% |
| 2022 | 4.07x | $264.90 Million | $65.10 Million | $90.59 Million | ▲ +306.8% |
| 2021 | 1.00x | $241.91 Million | $241.82 Million | $47.73 Million | ▼ -0.1% |
| 2020 | 1.00x | $379.38 Million | $379.00 Million | $61.84 Million | ▼ -98.5% |
| 2019 | 68.63x | $117.01 Million | $1.71 Million | $97.43 Million | ▲ +3380.0% |
| 2018 | 1.97x | $493.47 Million | $250.23 Million | $97.09 Million | ▲ +117.0% |
| 2017 | 0.91x | $212.82 Million | $234.19 Million | $114.27 Million | ▼ -58.0% |
| 2016 | 2.17x | $249.21 Million | $115.06 Million | $124.61 Million | ▲ +93.5% |
| 2015 | 1.12x | $117.38 Million | $104.88 Million | $117.38 Million | ▲ +58.3% |
| 2014 | 0.71x | $79.38 Million | $112.26 Million | $79.38 Million | — |